Advertisement
Organisation › Details
ConserV Bioscience Ltd.
ConserV Bioscience Limited, based in Oxfordshire, United Kingdom, is a clinical-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. Founded in 2020 as a spin-out from Seek (Peptcell Limited), it has an experienced scientific and leadership team. It is harnessing its novel in silico proprietary platform to identify highly conserved regions of viral proteins that contain a high number of reactive T-cell epitopes with extensive HLA coverage. In addition to its broad-spectrum coronavirus vaccine candidate, its pipeline includes vaccine candidates to protect against broad-spectrum influenza, mosquito-borne diseases, HIV, Hepatitis C, Hepatitis B, Rotavirus and Chagas. *
Start | 2020-10-05 established (s-off) | |
Industry | BIOTECH | |
Industry 2 | vaccine, SARS-CoV-2 (COVID-19) | |
Person | Duncan, Kimbell (ConserV Bioscience 202101 CEO) | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Street | 25 Walbrook The Walbrook Building | |
City | EC4N 8AF London | |
Address record changed: 2021-01-19 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine". London & Livermore, CA. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for ConserV Bioscience Ltd.
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top